other names
{{ Info.Overview }}
Revenue {{ Info.Revenue | formatUSD }}
Headquarters {{ Info.Headquarters }}

Adviser Profile

As of Date 04/05/2024
Adviser Type - Large advisory firm
Number of Employees 33 10.00%
of those in investment advisory functions 17 6.25%
Registration SEC, Approved, 03/30/2012
AUM* 12,092,862,376 58.92%
of that, discretionary 12,092,862,376 58.92%
Private Fund GAV* 12,092,862,376 58.92%
Avg Account Size 3,023,215,594 58.92%
SMA’s No
Private Funds 2
Contact Info 781 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Recent News

Reported AUM

Discretionary
Non-discretionary
11B 10B 8B 6B 5B 3B 2B
2015 2016 2017 2018 2019 2020 2021 2022 2023

Private Funds



Employees

Private Funds Structure

Fund Type Count GAV
Fund TypeHedge Fund Count1 GAV$11,141,722,303
Fund TypePrivate Equity Fund Count1 GAV$951,140,073

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM #Funds
Adviser KOPERNIK GLOBAL INVESTORS, LLC Hedge Fund363.9m Liquidity Fund- Private Equity Fund30.2m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV394.1m AUM5.5b #Funds3
Adviser DEERPATH CAPITAL MANAGEMENT, LP Hedge Fund2.2b Liquidity Fund- Private Equity Fund1.2b Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV3.3b AUM7.2b #Funds19
Adviser EDGE CAPITAL GROUP, LLC Hedge Fund75.2m Liquidity Fund- Private Equity Fund4.8m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV79.9m AUM6.4b #Funds2
Adviser ARBOUR LANE CAPITAL MANAGEMENT LP Hedge Fund757.3m Liquidity Fund- Private Equity Fund4.9b Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV5.7b AUM5.8b #Funds5
Adviser AXIUM INFRASTRUCTURE US INC. Hedge Fund5.9b Liquidity Fund- Private Equity Fund1.5b Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV7.4b AUM5.2b #Funds9
Adviser BOUSSARD & GAVAUDAN INVESTMENT MANAGEMENT LLP Hedge Fund- Liquidity Fund- Private Equity Fund4.1b Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV4.1b AUM3.7b #Funds1
Adviser CORNERSTONE PARTNERS Hedge Fund223.0m Liquidity Fund- Private Equity Fund98.2m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV321.3m AUM20.0b #Funds4
Adviser COMPASS GROUP LLC Hedge Fund36.7m Liquidity Fund- Private Equity Fund74.6m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund44.2m Total Private Fund GAV155.4m AUM2.1b #Funds3
Adviser STEADVIEW CAPITAL MANAGEMENT LLC Hedge Fund2.7b Liquidity Fund- Private Equity Fund162.1m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV2.9b AUM2.9b #Funds7
Adviser TIMUCUAN ASSET MANAGEMENT INC Hedge Fund741.3m Liquidity Fund- Private Equity Fund440.1k Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV741.7m AUM3.3b #Funds2

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck Ticker021369103 Stock NameALTAIR ENGR INC $ Position$1,187,189,300 % Position57.00% $ Change-3.00% # Change0.00%
Stck TickerG39387108 Stock NameGLOBALFOUNDRIES INC $ Position$664,726,818 % Position32.00% $ Change-22.00% # Change-2.00%
Stck TickerL7579L106 Stock NamePERIMETER SOLUTIONS SA $ Position$90,451,250 % Position4.00% $ Change55.00% # Change-10.00%
Stck Ticker05153U107 Stock NameAURA BIOSCIENCES INC $ Position$61,682,772 % Position3.00% $ Change18.00% # Change0.00%
Stck Ticker00653A107 Stock NameADAPTIMMUNE THERAPEUTICS PLC $ Position$35,812,512 % Position2.00% $ Change-6.00% # Change-3.00%
Stck Ticker98943L107 Stock NameZENTALIS PHARMACEUTICALS INC $ Position$51,372,701 % Position2.00% $ Change-10.00% # Change0.00%
Stck Ticker00650F109 Stock NameADAPTIVE BIOTECHNOLOGIES COR $ Position$3,328,000 % Position0.00% $ Change-92.00% # Change-94.00%

Brochure Summary

Overview

A. Matrix Capital Management Company, LP Matrix Capital Management Company, LP (“Matrix”), a Delaware limited partnership, commenced operations in 1999. Matrix is headquartered in Waltham, Massachusetts. David E. Goel and Paul J. Ferri are the founders of Matrix. David E. Goel, the Managing General Partner of Matrix, principally owns and controls Matrix and maintains ultimate authority over all investment decisions and the business affairs of Matrix. Matrix serves as the manager or management company, as the case may be, with discretionary investment authority to private pooled investment vehicles (each, a “Fund” and collectively, the “Matrix Funds”). All of the Matrix Funds are open-ended privately offered investment vehicles exempt from registration as investment companies under the Investment Company Act of 1940 (“1940 Act”). The Matrix Funds managed by Matrix include: i. Matrix Capital Management Fund, L.P., a Delaware limited partnership (the “Domestic Fund”); ii. Matrix Capital Management Fund (Offshore) Ltd., a Cayman Islands exempted company (the “Offshore Fund”, and together with the Domestic Fund, the “Feeder Funds”); and iii. Matrix Capital Management Master Fund, L.P., a Cayman Islands exempted limited partnership (the “Master Fund”), which serves as the Master Fund into which the Feeder Funds invest all of their investable assets through a “master- feeder” structure. Matrix General Partner, LP (the “Matrix General Partner”) is an affiliate of Matrix that also provides advisory services in its capacity as general partner of the Domestic Fund and the Master Fund (as defined above). Matrix manages the Matrix Funds pursuant to the investment strategy set forth in such Fund’s limited partnership agreement and offering memorandum (collectively, the “Matrix Governing Documents”). The Matrix Funds seek capital appreciation through investments principally in publicly-traded equity securities. Matrix does not provide specifically tailored investment advice to investors in the Matrix Funds, and investors may not impose investment restrictions on their investments in the Matrix
Funds. Matrix does not participate in wrap fee programs. As of December 31, 2023, Matrix’s regulatory assets under management were approximately $11,141,700,000, all of which are managed on a discretionary basis. Matrix does not manage assets on a non-discretionary basis. B. AyurMaya Capital Management Company, LP AyurMaya Capital Management Company, LP (“AyurMaya”, collectively with Matrix, the “Firm”), a Delaware limited partnership, commenced operations in 2021 and is a relying adviser on Matrix’s Form ADV. AyurMaya is headquartered in Waltham, Massachusetts. AyurMaya is solely owned and controlled by David E. Goel. AyurMaya serves as the manager with discretionary investment authority to the AyurMaya Capital Management Fund, LP, a Delaware limited partnership (the “AyurMaya Fund”, and together with the Matrix Funds, the “Funds” or “Clients”). The AyurMaya Fund is a closed-end, privately offered investment vehicle exempt from registration as an investment company under the 1940 Act. Unless the context otherwise requires, reference to the “Fund” includes the AyurMaya Fund. AyurMaya General Partner, LLC (the “AyurMaya General Partner”, collectively with the Matrix General Partner, the “General Partners”) is an affiliate of Matrix that also provides advisory services in its capacity as general partner of the AyurMaya Fund. AyurMaya manages the AyurMaya Fund pursuant to the investment strategy set forth in such Fund’s limited partnership agreement and offering memorandum (the “AyurMaya Governing Documents”). The AyurMaya Fund seeks to make, primarily, long-term investments in the equity and equity-related securities of companies in the tech/life sciences sector. AyurMaya does not provide specifically tailored investment advice to investors in the AyurMaya Fund, and investors may not impose investment restrictions on their investments in the Funds. AyurMaya does not participate in wrap fee programs. As of December 31, 2023, AyurMaya’s regulatory assets under management were approximately $951,100,000, all of which were managed on a discretionary basis. AyurMaya does not manage assets on a non-discretionary basis.